Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Oct-16 4:31 PM View:  | Morris Richard Steven Chief Financial Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 25-Oct-16 | Disposition | 828 | $21.00 | $17,388.00 | (100%) 0.83K to 0 | |
| 25-Oct-16 4:43 PM View: | Gregg Richard Chief Science Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 25-Oct-16 | Disposition | 228,274 | $21.00 | $4,793,750.00 | (50%) 456.55K to 228.27K | |
| 25-Oct-16 4:32 PM View: | Fratamico Arthur Chief Business Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 24-Oct-16 | Disposition (change in control) | 13,233 | $21.00 | $277,893.00 | (100%) 13.23K to 0 | |
| 25-Oct-16 4:34 PM View: | Gunderson Robert V Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 24-Oct-16 | Disposition (change in control) | 15,830 | $21.00 | $332,430.00 | (100%) 15.83K to 0 | |
| 25-Oct-16 4:33 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 24-Oct-16 | Disposition (change in control) | 244,996 | $21.00 | $5,144,920.00 | (50%) 489.99K to 245.0K | |
| 25-Oct-16 4:34 PM View: | Gunderson Robert V Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 24-Oct-16 | Disposition (change in control) | 11,002 | $21.00 | $231,042.00 | (41%) 26.83K to 15.83K | |
| 21-Oct-16 5:00 PM View: | Gregg Richard Chief Science Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 19-Oct-16 | Option Exercise | 123,902 | $5.27 | $652,795.00 | 119% 104.37K to 228.27K | |
| 16-Sep-16 4:03 PM View: | Adage Capital Partners Gp LLC 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 14-Sep-16 | Market Sale | 1,025,000 | $20.85 | $21,371,200.00 | (30%) 3.4M to 2.38M | (< 1%) |
| 16-Sep-16 5:00 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 14-Sep-16 | Market Sale (Planned) | 50,000 | $20.81 | $1,040,500.00 | (17%) 295.0K to 245.0K | (< 1%) |
| 17-Aug-16 5:08 PM View: | Morris Richard Steven Chief Financial Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Apr-16 | Grant | 828 | $6.11 | $5,059.08 | 100% 0 to 0.83K | |
| 17-Aug-16 5:09 PM View: | Gregg Richard Chief Science Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Apr-16 | Grant | 2,100 | $6.11 | $12,831.00 | 2% 102.27K to 104.37K | |
| 17-Aug-16 5:08 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Apr-16 | Grant | 747 | $6.11 | $4,564.17 | < 1% 294.25K to 295.0K | |
| 17-Aug-16 5:09 PM View: | Fratamico Arthur Chief Business Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Apr-16 | Grant | 2,086 | $6.11 | $12,745.50 | 21% 10.0K to 12.09K | |
| 21-Mar-16 9:32 PM View: | Hayden Donald J Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 21-Mar-16 | Market Option Sale (Planned) | 16,130 | $7.42 | $119,685.00 | (100%) 16.13K to 0 | (183%) |
| 21-Mar-16 9:32 PM View: | Hayden Donald J Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 21-Mar-16 | Option Exercise | 16,130 | $3.45 | $55,648.50 | 100% 0 to 16.13K | |
| 30-Dec-15 5:57 PM View: | Hayden Donald J Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Dec-15 | Option Exercise | 16,130 | $3.45 | $55,648.50 | 100% 0 to 16.13K | |
| 30-Dec-15 5:57 PM View: | Hayden Donald J Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Dec-15 | Market Option Sale (Planned) | 16,130 | $18.00 | $290,340.00 | (100%) 16.13K to 0 | (17%) |
| 28-Dec-15 4:30 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 28-Dec-15 | Option Exercise | 26,537 | $3.45 | $91,552.60 | 10% 267.36K to 293.9K | |
| 28-Dec-15 4:30 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 23-Dec-15 | Option Exercise | 22,524 | $3.45 | $77,707.80 | 8% 267.36K to 289.88K | |
| 28-Dec-15 4:30 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 23-Dec-15 | Market Option Sale (Planned) | 22,524 | $17.00 | $382,908.00 | (8%) 289.88K to 267.36K | (23%) |
| 17-Nov-15 4:30 PM View: | Gregg Richard Chief Scientific Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 16-Nov-15 | Option Exercise | 15,000 | $3.91 | $58,650.00 | 18% 85.56K to 100.56K | |
| 17-Nov-15 4:30 PM View: | Gregg Richard Chief Scientific Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 13-Nov-15 | Option Exercise | 85,557 | $4.15 | $354,779.00 | 100% 0 to 85.56K | |
| 22-Sep-15 5:31 PM View: | Hayden Donald J Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 21-Sep-15 | Market Option Sale (Planned) | 16,130 | $17.00 | $274,210.00 | (100%) 16.13K to 0 | (23%) |
| 22-Sep-15 5:31 PM View: | Hayden Donald J Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 21-Sep-15 | Option Exercise | 16,130 | $3.45 | $55,648.50 | 100% 0 to 16.13K | |
| 31-Aug-15 4:31 PM View: | Fratamico Arthur Chief Business Officer | Vitae Pharmaceuticals, Inc. (VTAE) | 27-Aug-15 | Market Purchase | 10,000 | $7.83 | $78,266.00 | 100% 0 to 10.0K | 168% |
| 02-Jul-15 4:42 PM View: | Barrett M James 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Disposition | 8,250 | -- | -- | (< 1%) 2.62M to 2.61M | |
| 02-Jul-15 4:39 PM View: | Nea Partners 10 L P 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Disposition (other) Duplicate | 825,000 | -- | -- | (31%) 2.62M to 1.79M | |
| 02-Jul-15 4:42 PM View: | Barris Peter J 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Acquisition (other) | 11,038 | -- | -- | < 1% 2.61M to 2.62M | |
| 02-Jul-15 4:42 PM View: | Barrett M James 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Acquisition (other) | 464 | -- | -- | < 1% 2.62M to 2.62M | |
| 02-Jul-15 4:42 PM View: | Sandell Scott D 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Disposition (other) Duplicate | 833,250 | -- | -- | (32%) 2.62M to 1.79M | |
| 02-Jul-15 4:01 PM View: | Newhall Charles W III Director | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Acquisition (other) | 289 | -- | -- | 100% 0 to 0.29K | |
| 02-Jul-15 4:39 PM View: | Nea Partners 10 L P 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Disposition (other) | 8,250 | -- | -- | (< 1%) 1.79M to 1.79M | |
| 02-Jul-15 4:42 PM View: | Barris Peter J 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Disposition (other) | 833,250 | -- | -- | (32%) 2.62M to 1.79M | |
| 02-Jul-15 4:42 PM View: | Barrett M James 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Disposition (other) Duplicate | 825,000 | -- | -- | (32%) 2.61M to 1.79M | |
| 02-Jul-15 4:39 PM View: | Nea Partners 10 L P 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Acquisition (other) | 8,250 | -- | -- | < 1% 2.61M to 2.62M | |
| 02-Jul-15 4:40 PM View: | New Enterprise Associates 1... 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Disposition (other) | 825,000 | -- | -- | (32%) 2.61M to 1.79M | |
| 02-Jul-15 4:42 PM View: | Barrett M James 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Acquisition (other) | 9,384 | -- | -- | < 1% 2.61M to 2.62M | |
| 02-Jul-15 4:42 PM View: | Sandell Scott D 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 01-Jul-15 | Acquisition (other) | 9,940 | -- | -- | < 1% 2.61M to 2.62M | |
| 22-May-15 4:30 PM View: | Hayden Donald J Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 20-May-15 | Option Exercise | 20,000 | $3.45 | $69,000.00 | 100% 0 to 20.0K | |
| 22-May-15 4:30 PM View: | Hayden Donald J Jr Director | Vitae Pharmaceuticals, Inc. (VTAE) | 20-May-15 | Market Option Sale | 20,000 | $12.01 | $240,200.00 | (100%) 20.0K to 0 | (75%) |
| 26-Mar-15 4:32 PM View: | Prospect Management Co II LLC 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 24-Mar-15 | Disposition (other) | 900,383 | -- | -- | (30%) 3.03M to 2.13M | |
| 26-Mar-15 4:32 PM View: | Prospect Management Co II LLC 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 24-Mar-15 | Acquisition (other) | 40,714 | -- | -- | 1% 2.99M to 3.03M | |
| 17-Mar-15 4:30 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 13-Mar-15 | Payment of Exercise | 171,156 | $11.16 | $1,910,100.00 | (39%) 438.52K to 267.36K | (88%) |
| 09-Mar-15 5:05 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 06-Mar-15 | Option Exercise | 8,115 | $1.15 | $9,332.25 | 2% 430.4K to 438.52K | |
| 26-Jan-15 4:31 PM View: | Hatfield Jeffrey S. Chief Executive Officer Director | Vitae Pharmaceuticals, Inc. (VTAE) | 22-Jan-15 | Option Exercise | 39,097 | $1.15 | $44,961.60 | 10% 391.3K to 430.4K | |
| 01-Oct-14 4:31 PM View: | Venrock Management III LLC 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Sep-14 | Conversion | 1,581,870 | -- | -- | 100% 0 to 1.58M | |
| 01-Oct-14 4:36 PM View: | New Enterprise Associates 1... 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Sep-14 | Conversion | 1,798,090 | -- | -- | 100% 0 to 1.8M | |
| 01-Oct-14 4:31 PM View: | Barrett Peter Director | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Sep-14 | Market Purchase | 37,500 | $8.00 | $300,000.00 | 3% 1.14M to 1.17M | 162% |
| 01-Oct-14 9:03 PM View: | Prospect Management Co II LLC 10% Owner | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Sep-14 | Market Purchase | 671,807 | $8.00 | $5,374,460.00 | 28% 2.36M to 3.03M | 162% |
| 01-Oct-14 4:31 PM View: | Barrett Peter Director | Vitae Pharmaceuticals, Inc. (VTAE) | 29-Sep-14 | Conversion | 1,136,820 | -- | -- | 100% 0 to 1.14M |
